Quantum-Si incorporated (QSI) has a MoatMap StockRank of 8/100 based on Quality (33/100), Value (38/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL. A life sciences company commercializing single-molecule protein sequencing. It is in the early commercialization phase with heavy losses and unproven market demand.
Quantum-Si incorporated develops a next-generation protein sequencing platform, aiming to revolutionize proteomics research and drug discovery. Its proprietary semiconductor chip-based technology enables single-molecule protein sequencing, offering unprecedented insights into protein biology. This innovative approach positions Quantum-Si as a potential disruptor in the life sciences tools market, providing a distinct technological moat in an emerging high-growth area.
| Price | $0.99 |
| Market Cap | $261M |
| P/E (Forward) | -3.56 |
| Price/Book | 1.39 |
| Return on Equity | -46.4% |
| Return on Invested Capital | -43.7% |
| Debt/Equity | 1.85 |
| Gross Margin | 40.0% |
| Operating Margin | -9322.9% |
| Revenue Growth | -69.4% |
| Free Cash Flow | $-46M |
Quantum-Si incorporated operates in the Medical Devices industry, part of the Healthcare sector (United States).